- Home
- HNRG vs ANGO Comparison
HNRG vs ANGO Comparison
Compare HNRG & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNRG
- ANGO
- Stock Information
- Founded
- HNRG 1949
- ANGO 1988
- Country
- HNRG United States
- ANGO United States
- Employees
- HNRG N/A
- ANGO N/A
- Industry
- HNRG Coal Mining
- ANGO Medical/Dental Instruments
- Sector
- HNRG Energy
- ANGO Health Care
- Exchange
- HNRG Nasdaq
- ANGO Nasdaq
- Market Cap
- HNRG 413.8M
- ANGO 439.5M
- IPO Year
- HNRG N/A
- ANGO 2004
- Fundamental
- Price
- HNRG $14.37
- ANGO $9.52
- Analyst Decision
- HNRG Strong Buy
- ANGO Strong Buy
- Analyst Count
- HNRG 2
- ANGO 2
- Target Price
- HNRG $16.00
- ANGO $14.00
- AVG Volume (30 Days)
- HNRG 928.8K
- ANGO 674.1K
- Earning Date
- HNRG 05-05-2025
- ANGO 04-02-2025
- Dividend Yield
- HNRG N/A
- ANGO N/A
- EPS Growth
- HNRG N/A
- ANGO N/A
- EPS
- HNRG N/A
- ANGO N/A
- Revenue
- HNRG $404,394,000.00
- ANGO $283,320,000.00
- Revenue This Year
- HNRG $3.82
- ANGO N/A
- Revenue Next Year
- HNRG $26.97
- ANGO $6.35
- P/E Ratio
- HNRG N/A
- ANGO N/A
- Revenue Growth
- HNRG N/A
- ANGO N/A
- 52 Week Low
- HNRG $4.33
- ANGO $5.47
- 52 Week High
- HNRG $14.00
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- HNRG 64.87
- ANGO 48.91
- Support Level
- HNRG $13.08
- ANGO $9.26
- Resistance Level
- HNRG $13.95
- ANGO $9.94
- Average True Range (ATR)
- HNRG 1.08
- ANGO 0.65
- MACD
- HNRG 0.21
- ANGO 0.01
- Stochastic Oscillator
- HNRG 92.92
- ANGO 26.17
About HNRG Hallador Energy Company
Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry. The operations of the company are divided into two primary reportable segments, the Coal Operations and Electric Operations segments. The majority of revenue is earned from the Coal Operations segment.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.